They copped it for how they delivered the 6 month data, so it just looks like they're giving themselves a bit of time to best package this new information for release to the general market.
Just another landmark reached. This data completes the 008 set, so they can now a) further inform interested partners on duration of treatment effects, and b) begin arrangements to discuss potential for DMOAD clinical trial pathway with the FDA.
They copped it for how they delivered the 6 month data, so it...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
-0.005(1.75%) |
Mkt cap ! $99.69M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 29.0¢ | 27.5¢ | $68.09K | 241.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 40048 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 23265 | 10 |
View Market Depth
| Last trade - 15.01pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
28.0¢ |
Change
-0.005 ( 1.23 %) |
||||
| Open | High | Low | Volume | ||
| 28.0¢ | 29.0¢ | 27.5¢ | 106693 | ||
| Last updated 15.01pm 16/05/2024 ? | |||||
| PAR (ASX) Chart |